| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.09 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |